Lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age 65 years and above; 2) Patients whose lung cancer diagnoses are all in accordance with the Chinese Medical Association Lung Cancer Clinical Diagnosis and Treatment Guidelines (2018 Edition) and who are proposed to undergo thoracoscopic lobectomy; 3) Patients who are conscious, without cognitive, speech and motor dysfunction and contraindications to exercise; 4) Patients and their families who agreed to be enrolled and signed the clinical informed consent to participate in this study; 5) American Society of Anaesthesiologists ASA classification I-III;
Exclusion criteria
Exclusion criteria: 1) Patients with multiple metastases throughout the body; 2) Patients with proposed total lung or two or more lobectomies; 3) patients receiving adjuvant treatment such as radiotherapy or chemotherapy; 4) Patients with severe organic lesions or insufficiency of organs such as heart, brain and kidney; 5) Patients with severe physical behavioural limitations requiring bed rest; 6) Patients with communication problems such as severe hearing, vision or speech disorders; 7) Patients with mental disorders; 8) Patients who have participated in other relevant clinical studies within 3 months;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6-minute walk distance; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Score;Functional assessment of cancer therapy-lung;Postoperative tube placement time;Post-operative length of stay; | — |
Countries
China
Contacts
Shanghai Fourth People's Hospital